H. Yu et al. / Tetrahedron Letters 54 (2013) 1256–1260
1259
Br
O
R
E
4556–4559; (h) Dong, J.-Q.; Wong, H. N. C. Angew. Chem., Int. Ed. 2009, 48,
2351–2354.
8. McDermott, P. J.; Stockman, R. A. Org. Lett. 2005, 7, 27–29.
9. (a) Butin, A. V.; Stroganova, T. A.; Lodina, I. V.; Krapivin, G. D. Tetrahedron Lett.
2001, 42, 2031–2033; (b) Butin, A. V.; Smirnov, S. K.; Stroganova, T. A.; Bender,
W.; Krapivin, G. D. Tetrahedron 2006, 63, 474–491.
10. (a) Gao, Y.; Wu, W.-L.; Ye, B.; Zhou, R.; Wu, Y.-L. Tetrahedron Lett. 1996, 37,
893–896; (b) Yin, B.-L.; Yang, Z.-M.; Hu, T.-S.; Wu, Y.-L. Synthesis 2003, 1995–
2000; (c) Chen, L.; Xu, H.-H.; Yin, B.-L.; Xiao, C.; Hu, T.-S.; Wu, Y.-L. J. Agric. Food
Chem. 2004, 52, 6719–6723; (d) Yin, B.-L.; Lai, J.-Q.; Zhang, Z.-R.; Jiang, H.-F.
Adv. Synth. Catal. 2011, 353, 1961–1965; (e) Yin, B.; Huang, L.; Zhang, X.; Ji, F.;
Jiang, H. J. Org. Chem. 2012, 77, 6365–6370.
11. (a) Yin, B.; Zeng, G.; Cai, C.; Ji, F.; Huang, L.; Li, Z.; Jiang, H. Org. Lett. 2012, 14,
616–619; (b) Yin, B.; Cai, C.; Zeng, G.; Zhang, R.; Li, X.; Jiang, H. Org. Lett. 2012,
14, 1098–1101.
2
O
R
E
O
R
2
+
2
NBS
Br
+
R
O
R
R
H
O
O
E
R
1
5
R
R
13
1
1
12
Br
Br
Br
O
+
O
O
R
H
R
2
R
+
2
+
2
R
O
R
R
R
O
OH
R
H
R
14
E
1
R
E
1
E
1
15
H
16
Br
O
O
R
2
2
12. Typical procedure for the synthesis of 6: To a 25 mL flask was added 5 (0.3 mmol,
1 equiv), THF (3 mL), H2O (1 mL), AcOH (0.03 mmol, 0.1 equiv), and NBS
(0.33 mmol, 1.1 equiv). The mixture was stirred for 30 min at room
temperature until the disappearance of 5 according to the TLC. The reaction
mixture then was heated to 80 °C for 15 h. After cooled to room temperature,
the reaction mixture was added saturated Na2S2O3 solution (5 mL) and
extracted with EtOAc (3 Â 10 mL). The combined organic layers were washed
with saturated NaHCO3 solution and brine, dried over Na2SO4. After removal of
the solvent, the residue was purified by flash column chromatography to afford
6.
6
R
R
OH
R
17
O
E
R
18
E
1
1
Scheme 4. The proposed mechanism for the formation of 6.
Acknowledgments
Compound 6a: 1H NMR (400 MHz, CDCl3) d 7.17 (d, J = 15.9 Hz, 1H), 6.88 (s, 1H),
6.58 (d, J = 15.9 Hz, 1H), 4.28 (q, J = 7.1 Hz, 2H), 2.61 (s, 3H), 2.31 (s, 3H), 1.34 (t,
J = 7.1 Hz, 3H); 13C NMR (101 MHz, CDCl3) d 197.5, 163.1, 161.6, 148.5, 128.6,
124.4, 116.4, 116.1, 60.4, 28.0, 14.3, 14.1.
This work was supported by the Fundamental Research Funds
for the Central Universities (2012ZZ043), the National Natural
Science Foundation of China (21072062, 21272078), and the
Natural Science Foundation of Guangdong Province, China
(10351064101000000).
Compound 6b: 1H NMR (400 MHz, CDCl3) d 7.21 (d, J = 15.9 Hz, 1H), 6.87 (s, 1H),
6.62 (d, J = 15.9 Hz, 1H), 2.65 (s, 3H), 2.43 (s, 3H), 2.34 (s, 3H); 13C NMR
(101 MHz, CDCl3) d 197.4, 193.3, 161.0, 148.5, 128.4, 124.6, 123.7, 115.5, 29.0,
28.0, 14.6.
Compound 6c: 1H NMR (400 MHz, CDCl3) d 7.84 (d, J = 7.5 Hz, 2H), 7.75 (dd,
J = 6.4, 2.9 Hz, 2H), 7.54 (t, J = 7.4 Hz, 1H), 7.41 (t, J = 7.7 Hz, 2H), 7.37–7.30 (m,
3H), 7.27 (d, J = 4.9 Hz, 1H), 6.92 (s, 1H), 6.77 (d, J = 15.9 Hz, 1H), 2.37 (s, 3H);
13C NMR (101 MHz, CDCl3) d 197.4, 190.9, 157.3, 149.1, 137.5, 133.35, 129.9,
129.7, 128.9, 128.5, 128.4, 127.7, 126.9, 125.5, 123.2, 118.6, 28.0.
Supplementary data
Supplementary data associated with this article can be found, in
Compound 6g: 1H NMR (400 MHz, CDCl3)
d 7.33–7.20 (m, 1H), 6.56 (d,
J = 15.6 Hz, 1H), 4.28 (q, J = 7.1 Hz, 2H), 2.72 (q, J = 7.4 Hz, 2H), 2.57 (s, 3H), 2.29
(s, 3H), 1.33 (t, J = 7.1 Hz, 3H), 1.13 (t, J = 7.4 Hz, 3H); 13C NMR (101 MHz,
CDCl3) d 197.5, 163.5, 162.0, 145.0, 134.0, 126.3, 122.4, 115.2,, 60.2, 28.4, 17.8,
15.4, 14.6, 14.1.
Compound 6h: 1H NMR (400 MHz, CDCl3) d 7.47 (d, J = 15.5 Hz, 1H), 6.58 (d,
J = 15.5 Hz, 1H), 4.30 (q, J = 7.1 Hz, 2H), 3.19–3.02 (m, 1H), 2.54 (s, 3H), 2.31 (s,
3H), 1.84–1.68 (m, 7H), 1.43–1.29 (m, 6H); 13C NMR (101 MHz, CDCl3) d 197.5,
163.9, 161.4, 144.8, 136.8, 128.1, 122.6, 115.5, 60.3, 35.8, 32.6, 28.6, 27.0, 25.9,
14.9.
References and notes
1. For selected reviews, see: (a) Keay, B. A.; Hopkins, J. M.; Dibble, P. W. In
Comprehensive Heterocyclic Chemistry I; Jones, G., Ramsden, C. A., Eds.;
Elsevier: Amsterdam, 2008; Vol. 3, p 571; (b) d’lschia, M.; Napolitano, A.;
Pezzella, A. In Comprehensive Heterocyclic Chemsitry I; Jones, G., Ramsden, C.
A., Eds.; Elsevier: Amsterdam, 2008; Vol. 3, p 353; (c) Lipshutz, B. H. Chem. Rev.
1986, 86, 795–820; (d) Nakanishi, K. Natural Products Chemistry; Kodansha:
Tokyo, 1974.
2. For reviews concerning the dearomatization of furan ring, see: (a) Bach, T.
Angew. Chem., Int. Ed. Engl. 1996, 35, 729–730; (b) Bur, S. K.; Padwa, A. Chem.
Rev. 2004, 104, 2401–2432.
3. (a) Gribble, G. W. In Comprehensive Organic Synthesis; Trost, B. M., Fleming, I.,
Eds.; Pergamon: Oxford, 1991; Vol. 8, p 603; (b) Donohoe, T. J.; Garg, R.;
Stevenson, C. A. Tetrahedron: Asymmetry 1996, 7, 317–344; (c) Donohoe, T. J.;
Calabrese, A.; Stevenson, A. C. A.; Ladduwahetty, T. J. Chem. Soc., Perkin Trans. 1
2000, 3724–3731.
4. (a) Hosomi, A.; Tominaga, Y. In Comprehensive Organic Synthesis; Trost, B. M.,
Fleming, I., Paquette, L. A., Eds.; Pergamon: Oxford, 1991; Vol. 5, p 593; (b)
Chen, C.-H.; Rao, P. D.; Liao, C.-C. J. Am. Chem. Soc. 1998, 120, 13254–13255; (c)
Domingo, L. R.; Aurell, M. J. J. Org. Chem. 2002, 67, 959–965; (d) Xiong, H.;
Hsung, R. P.; Berry, C. R.; Rameshkumar, C. J. Am. Chem. Soc. 2001, 123, 7174–
7175; (e) Davies, H. M. L.; Ahmed, G.; Churchill, M. R. J. Am. Chem. Soc. 1996,
118, 10774–10782; (f) Kappe, C. O.; Murphree, S. S.; Padwa, A. Tetrahedron
1997, 53, 14179–14233; (g) Liu, L.; Gao, Y.; Che, C.; Wu, N.; Wang, D. Z.; Li, C.-
C.; Yang, Z. Chem. Commun. 2009, 662–664.
5. (a) Veits, G. K.; Wenz, D. R.; de Alanz, J. R. Angew. Chem., Int. Ed. 2010, 49, 9484–
9487; (b) Palmer, L. I.; de Alaniz, J. R. Angew. Chem., Int. Ed. 2011, 50, 7167–
7170; (c) Dygos, J. H.; Adamek, J. P.; Babiak, K. A.; Behling, J. R.; Medich, J. R.; Ng,
J. S.; Wieczorek, J. J. J. Org. Chem. 1991, 56, 2549–2552; (d) Rodriguez, A.;
Nomen, M.; Spur, B. W.; Godfroid, J. Eur. J. Org. Chem. 1999, 2655–2662; (e) Yin,
B. L.; Wu, Y.-K.; Wu, Y.-L. J. Chem. Soc., Perkin Trans. 1 2002, 1746–1747.
6. The example concerning the synthesis of furan via the ring opening of the
furans, see: Richard, T.; Cummings, R. T.; DiZio, J. P.; Krafft, G. A. Tetrahedron
Lett. 1988, 29, 69–72.
7. (a) Georgiou, T.; Tofi, M.; Montagnon, T.; Vassilikogiannakis, G. Org. Lett. 2006,
8, 1945–1948; (b) McDermott, P. J.; Stockman, R. A. Org. Lett. 2005, 7, 27–29; (c)
Jackson, K. L.; Henderson, J. A.; Morris, J. C.; Motoyoshi, H.; Phillips, A. J.
Tetrahedron Lett. 2008, 49, 2939–2941; (d) Abrams, J. N.; Babu, R. S.; Guo, H.; Le,
D.; Le, J.; Osbourn, J. M.; O’Doherty, G. A. J. Org. Chem. 2008, 73, 1935–1940; (e)
Bi, J.; Aggarwal, V. K. Chem. Commun. 2008, 120–122; (f) Cong, X.; Liu, K.-G.;
Liao, Q.-J.; Yao, Z.-J. Tetrahedron Lett. 2005, 46, 8567–8571; (g) Pavlakos, E.;
Georgiou, T.; Tofi, M.; Montagnon, T.; Vassilikogiannakis, G. Org. Lett. 2009, 11,
Compound 6i: 1H NMR (400 MHz, CDCl3) d 7.42–7.37 (m, 3H), 7.30–7.26 (m,
2H), 7.07 (d, J = 15.9 Hz, 1H), 6.65 (d, J = 15.9 Hz, 1H), 4.13 (q, J = 7.1 Hz, 2H),
2.67 (s, 3H), 2.24 (s, 3H), 1.09 (t, J = 7.1 Hz, 3H); 13C NMR (101 MHz, CDCl3) d
197.5, 163.2, 161.5, 146.0, 131.8, 131.1, 130.0, 128.1, 127.9, 127.6, 124.5, 115.7,
60.2, 28.0, 14.5, 13.8.
Compound 6j: 1H NMR (400 MHz, CDCl3) d 7.43 (d, J = 6.6 Hz, 3H), 7.25 (dd,
J = 7.6, 2.0 Hz, 2H), 6.99 (d, J = 15.8 Hz, 1H), 6.63 (d, J = 15.8 Hz, 1H), 2.60 (s,
3H), 2.21 (s, 3H), 1.91 (s, 3H); 13C NMR (101 MHz, CDCl3) d 197.4, 195.2, 160.4,
145.8, 131.4, 130.9, 129.7, 128.8, 128.7, 127.3, 124.7, 124.5, 30.7, 28.2, 14.6.
Compound 6k: 1H NMR (400 MHz, CDCl3) d 8.30 (d, J = 8.7 Hz, 2H), 7.46 (d,
J = 8.7 Hz, 2H), 6.93 (d, J = 15.7 Hz, 1H), 6.70 (d, J = 15.7 Hz, 1H), 2.65 (s, 3H),
2.25 (s, 3H), 2.08 (s, 3H); 13C NMR (101 MHz, CDCl3) d 197.2, 193.7, 160.6,
147.8, 146.2, 138.4, 130.8, 128.4, 126.0, 125.7, 124.3, 123.8, 30.8, 28.5, 14.9.
Compound 6l: 1H NMR (400 MHz, CDCl3) d 8.28 (d, J = 8.7 Hz, 2H), 7.46 (d,
J = 8.7 Hz, 2H), 7.02 (d, J = 15.8 Hz, 1H), 6.69 (d, J = 15.8 Hz, 1H), 4.15–4.09 (m,
2H), 2.28 (s, 3H), 1.47 (s, 9H), 1.06 (t, J = 7.1 Hz, 3H); 13C NMR (101 MHz, CDCl3)
d 197.2, 167.5, 163.8, 147.6, 144.7, 138.4, 130.5, 129.6, 128.8, 126.4, 125.7,
123.5, 123.3, 115.6, 61.2, 35.1, 28.5, 28.3, 13.7.
Compound 6m: 1H NMR (400 MHz, CDCl3) d 7.79 (d, J = 7.3 Hz, 2H), 7.64 (dd,
J = 6.6, 2.9 Hz, 2H), 7.44 (t, J = 7.4 Hz, 1H), 7.36–7.19 (m, 8H), 6.99 (t, J = 8.6 Hz,
2H), 6.90 (d, J = 15.8 Hz, 1H), 2.34 (s, 3H); 13C NMR (101 MHz, CDCl3) d 197.4,
192.5, 164.0, 161.5, 153.92, 146.3, 136.8, 133.9, 132.1, 131.2, 131.2, 129.7,
129.7, 128.8, 128.6, 128.6, 127.1, 126.8, 126.4, 125.5, 123.3, 116.0, 115.8, 28.3.
Compound 6n: 1H NMR (400 MHz, CDCl3)
d 7.34–7.25 (m, 2H), 7.17 (t,
J = 8.6 Hz, 2H), 6.99 (d, J = 15.8 Hz, 1H), 6.67 (d, J = 15.8 Hz, 1H), 2.64 (s, 3H),
2.26 (s, 3H), 1.98 (s, 3H); 13C NMR (101 MHz, CDCl3) d 197.3, 194.8, 164.2,
161.7, 160.5, 146.0, 131.6, 131.5, 129.7, 127.4, 127.4, 126.9, 124.7, 124.6, 116.0,
115.8, 30.8, 28.3, 14.7.
Compound 6o: 1H NMR (400 MHz, CDCl3) d 7.18 (d, J = 8.7 Hz, 2H), 7.02 (d,
J = 15.8 Hz, 1H), 6.97 (d, J = 8.7 Hz, 2H), 6.62 (d, J = 15.8 Hz, 1H), 3.85 (s, 3H),
2.60 (s, 3H), 2.23 (s, 3H), 1.95 (s, 3H); 13C NMR (101 MHz, CDCl3) d 197.45,
195.39, 160.33, 159.90, 145.82, 130.91, 130.77, 127.43, 124.74, 124.16, 123.39,
114.26, 55.29, 30.69, 28.16, 14.63.
Compound 6p: 1H NMR (400 MHz, CDCl3) d 7.19 (q, J = 8.0 Hz, 4H), 7.08 (d,
J = 15.9 Hz, 1H), 6.63 (d, J = 15.9 Hz, 1H), 4.15 (q, J = 7.1 Hz, 2H), 2.66 (s, 3H),
2.39 (s, 3H), 2.24 (s, 3H), 1.13 (t, J = 7.1 Hz, 3H); 13C NMR (101 MHz, CDCl3) d
197.5, 163.2, 161.4, 146.0, 137.9, 132.0, 129.9, 128.6, 128.0, 127.8, 124.3, 115.7,
60.2, 27.9, 21.2, 14.5, 13.9.